Allogeneic hematopoietic stem cell transplantation using HLA-compatible donors in younger high cytogenetic risk CLL patients results in very high long-term progression-free survival and may therefore favorably compete with sequential targeted therapy

van Gelder, M (author)

Ziagkos, D (author)

de Wreede, L (author)

show more...

van Biezen, A (author)

Dreger, P (author)

Gramatzki, M (author)

Stelljes, M (author)

Andersen, NS (author)

Schaap, N (author)

Vitek, A (author)

Beelen, D (author)

Volin, L (author)

Finke, J (author)

Passweg, J (author)

Eder, M (author)

Machaczka, M (author)

Karolinska Institutet

Delgado, J (author)

Kruger, W (author)

Raida, L (author)

Socie, G (author)

Jindra, P (author)

Afanasyev, B (author)

Wagner, E (author)

Chalandon, Y (author)

Henseler, A (author)

Schoenland, S (author)

Kroger, N (author)

Schetelig, J (author)

show less...

 (creator_code:org_t)

2017

2017

English.

In: LEUKEMIA & LYMPHOMA. - 1042-8194. ; 58, s. 90-93

Related links:

http://kipublication...

• Conference paper (other academic/artistic)